Global State of Harm Reduction Reports
Harm Reduction International’s flagship publication is the biennial Global State of Harm Reduction report. First published in 2008, it involves a coordinated effort across practitioners, academics, advocates and activists to map global data and responses to HIV and hepatitis C epidemics related to unsafe injecting and non-injecting drug use.
Low Dead Space Injecting Equipment: A Briefing
Maximising the Effectiveness of Needle Exchange with low dead space syringes and prevention of accidental sharing, this briefing by Exchange Supplies is a free 24 page book that is a comprehensive guide to addressing these two key areas of injecting related risk. Giving full descriptions of the advantages of low dead space injecting equipment and […]
Hepatitis C in the UK
Hepatitis C virus (HCV) is a major public health threat in the UK. These reports summarise the scale of the problem and are intended to support focused action.
Deaths related to drug poisoning in England and Wales Statistical bulletins
This bulletin presents the latest figures from the Office for National Statistics (ONS) on deaths related to drug poisoning (involving both legal and illegal drugs) and drug misuse (involving illegal drugs) in England and Wales.
Alternatives to Public Injecting
Harm Reduction Coalition invited experts from several countries to share their various SIF models, planning and policy development process, implementation challenges, and evaluation results. This report is a summary of the proceedings of the consultation.
Safer Drug Consumption Facilities and Heroin Assisted Treatment (FAQs)
Safer drug consumption facilities (SDCFs) are clean, hygienic environments where people can consume drugs, obtained elsewhere, under the supervision of trained health professionals.
Drug consumption rooms: An overview of provision and evidence
Supervised drug consumption facilities, where illicit drugs can be used under the supervision of trained staff, have been operating in Europe for the last three decades.
Step by Step
This resource is intended for harm reduction service providers with limited experience of working with children and young people who inject drugs. It sets out a process that you can go through quickly, with little cost, to prepare for work with children and young people who are under 18.
Preventing blood-borne virus transmission among people who inject drugs
Preventing the transmission of blood-borne viruses (BBV) such as HIV, hepatitis B and hepatitis C among people who inject drugs can have wide-reaching benefits: reducing health harms to individuals and subsequent costs to society.